{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:19:21Z","timestamp":1793744361807,"version":"4.6.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","award":["UL1TR004419"],"award-info":[{"award-number":["UL1TR004419"]}],"id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI07647"],"award-info":[{"award-number":["AI07647"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD026880"],"award-info":[{"award-number":["S10OD026880"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD030463"],"award-info":[{"award-number":["S10OD030463"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xcrm.2026.102786","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:16:29Z","timestamp":1777994189000},"page":"102786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-313X","authenticated-orcid":false,"given":"Guillaume","family":"Mestrallet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Vaninov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Woo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandra","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Ananthanarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Vabret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Cimen Bozkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Samstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102786_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1210164","article-title":"Immune escape and resistance to immunotherapy in mismatch repair deficient tumors","volume":"14","author":"Mestrallet","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102786_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM200001133420201","article-title":"Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer","volume":"342","author":"Gryfe","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102786_bib3","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0016-5085(99)70499-3","article-title":"Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features","volume":"116","author":"Yamamoto","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.102786_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102786_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102786_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1126\/science.aau0447","article-title":"Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response","volume":"364","author":"Mandal","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102786_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102786_bib8","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102786_bib9","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability\u2013High Advanced Colorectal Cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102786_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","article-title":"Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair\u2013Deficient\/Microsatellite Instability\u2013High Metastatic Colorectal Cancer","volume":"36","author":"Overman","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102786_bib11","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJMc2031965","article-title":"The Spectrum of Benefit from Checkpoint Blockade in Hypermutated Tumors","volume":"384","author":"Rousseau","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102786_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study","volume":"23","author":"Diaz","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102786_bib13","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cell.2020.11.004","article-title":"Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors","volume":"183","author":"Roudko","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jamaoncol.2018.1482","article-title":"Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome","volume":"4","author":"Chang","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.xcrm.2026.102786_bib15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.gastro.2021.11.029","article-title":"The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients","volume":"162","author":"Bohaumilitzky","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.102786_bib16","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib17","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","article-title":"Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/2159-8290.CD-17-1327","article-title":"Genetic Mechanisms of Immune Evasion in Colorectal Cancer","volume":"8","author":"Grasso","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102786_bib19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ccell.2022.08.005","article-title":"NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer","volume":"40","author":"Salom\u00e9","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41586-022-05105-1","article-title":"MYB orchestrates T cell exhaustion and response to checkpoint inhibition","volume":"609","author":"Tsui","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102786_bib21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/2326-6066.CIR-18-0891","article-title":"Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth","volume":"7","author":"Roumenina","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.102786_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102786_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109844","article-title":"Targeting TREM2 on tumor-associated macrophages enhances immunotherapy","volume":"37","author":"Binnewies","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102786_bib24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2020.06.032","article-title":"Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer","volume":"182","author":"Katzenelenbogen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib25","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","article-title":"TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer","volume":"24","author":"Park","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.102786_bib27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.it.2020.09.002","article-title":"The transcription factor Bhlhe40 in immunity and autoimmunity","volume":"41","author":"Cook","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2026.102786_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137263","article-title":"CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity","volume":"5","author":"Huffman","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.102786_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41417-019-0093-y","article-title":"High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia","volume":"27","author":"Liu","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102786_bib31","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s11033-021-06919-4","article-title":"Interferon-induced transmembrane protein 2 promotes epithelial-mesenchymal transition by activating transforming growth factor-\u03b21\/small mother against decapentaplegic 2 signaling in gastric cancer","volume":"49","author":"Liu","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.xcrm.2026.102786_bib32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ccell.2019.04.003","article-title":"Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation","volume":"35","author":"Segovia","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2021.06.064","article-title":"Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts","volume":"161","author":"Bortolomeazzi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.102786_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111929","article-title":"Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer","volume":"42","author":"Ozato","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102786_bib35","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.cell.2018.09.030","article-title":"High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy","volume":"175","author":"Gubin","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.acthis.2011.12.006","article-title":"Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology","volume":"114","author":"Cuajungco","year":"2012","journal-title":"Acta Histochem."},{"key":"10.1016\/j.xcrm.2026.102786_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005059","article-title":"Overcoming resistance to \u03b1PD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of \u03b1CTLA-4 and \u03b1PD-1 blockers","volume":"10","author":"Nebot-Bral","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102786_bib38","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/s41591-023-02544-9","article-title":"Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade","volume":"29","author":"Harrold","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102786_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-023-06733-x","article-title":"Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer","volume":"624","author":"Zhou","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102786_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008689","article-title":"Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study","volume":"12","author":"Overman","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102786_bib41","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2400634","article-title":"Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair\u2013Deficient Colon Cancer","volume":"390","author":"Chalabi","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102786_bib42","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1016\/j.cell.2024.06.036","article-title":"Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity","volume":"187","author":"Cillo","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib43","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","article-title":"LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-\u03b3-dependent anti-tumor immunity","volume":"187","author":"Andrews","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib44","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","article-title":"T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants","volume":"186","author":"Hirschhorn","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ccell.2022.11.014","article-title":"IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer","volume":"41","author":"Blomberg","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102786_bib46","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41586-022-05593-1","article-title":"\u03b3\u03b4 T cells are effectors of immunotherapy in cancers with HLA class I defects","volume":"613","author":"de Vries","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102786_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.980709","article-title":"Strategies to overcome DC dysregulation in the tumor microenvironment","volume":"13","author":"Mestrallet","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102786_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay1863","article-title":"Targeted deletion of PD-1 in myeloid cells induces antitumor immunity","volume":"5","author":"Strauss","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2026.102786_bib49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20554","article-title":"Overcoming Resistance to Checkpoint Blockade Therapy by Targeting PI3K-\u03b3 in Myeloid Cells","volume":"539","author":"De Henau","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102786_bib50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/bjc.2013.696","article-title":"Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients","volume":"110","author":"Zeestraten","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102786_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144000","article-title":"HLA-G 3\u2019UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment","volume":"10","author":"Garziera","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102786_bib52","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/cells10061438","article-title":"Human Keratinocytes Inhibit CD4+ T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints","volume":"10","author":"Mestrallet","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.102786_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.786859","article-title":"Immunosuppressive Properties of Epidermal Keratinocytes Differ According to Their Immaturity Status","volume":"13","author":"Mestrallet","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102786_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.772516","article-title":"Skin Immunity and Tolerance: Focus on Epidermal Keratinocytes Expressing HLA-G","volume":"12","author":"Mestrallet","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102786_bib55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-0039.2011.01716.x","article-title":"Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer","volume":"78","author":"Cao","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.xcrm.2026.102786_bib56","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-024-07350-y","article-title":"Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers","volume":"629","author":"Ferretti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102786_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add9990","article-title":"TREM1 activation of myeloid cells promotes antitumor immunity","volume":"15","author":"Juric","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102786_bib58","article-title":"Targeting neoantigens conserved across organs and species overcomes tumor immune escape","author":"Mestrallet","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.102786_bib59","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102786_bib60","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/2326-6066.CIR-24-0416","article-title":"T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNF\u03b1 Inflammation","volume":"13","author":"Cho","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.102786_bib61","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102786_bib62","article-title":"A 3D Spheroid Model for Glioblastoma","volume":"158","author":"Guyon","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.xcrm.2026.102786_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.898732","article-title":"Methods for Establishing a Renal Cell Carcinoma Tumor Spheroid Model With Immune Infiltration for Immunotherapeutic Studies","volume":"12","author":"Lugand","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2026.102786_bib64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102786_bib65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.12688\/f1000research.16665.2","article-title":"Sarek: A portable workflow for whole-genome sequencing analysis of germline and somatic variants","volume":"9","author":"Garcia","year":"2020","journal-title":"F1000Research"},{"key":"10.1016\/j.xcrm.2026.102786_bib66","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102786_bib67","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/cancers16020408","article-title":"Predicting Immunotherapy Outcomes in Glioblastoma Patients through Machine Learning","volume":"16","author":"Mestrallet","year":"2024","journal-title":"Cancers"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912600203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912600203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:53:12Z","timestamp":1783119192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266637912600203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S266637912600203X"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102786","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102786"}}